Curavit
Boston, US · 2 known investors
Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.
Founders & leadership
JM
Joel MorseFounder & CEO
PD
Pam DiamondCo-founder & Chief Medical Officer
DH
Dave HanamanCo-founder, President & Chief Commercial Officer
Investors · 2
Competitors · 2
by search overlap
IQVIA13 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Velocity Clinical Research7 shared keywordsVelocity operates dedicated and embedded clinical research sites across the United States, providing the staff, equipment, study contracting, regulatory documentation, and business development support needed to run clinical trials. It partners with physician groups, independent practices, and health centers to add research capabilities and covers a wide range of therapeutic areas.
Companies competing with Curavit for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Curavit do?
- Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.
- Who founded Curavit?
- Curavit was founded by Joel Morse, Pam Diamond, Dave Hanaman.
- Who are Curavit's investors?
- Curavit's investors include Royal Street Ventures Management Company, Llc, Osage Venture Partners.
- Where is Curavit headquartered?
- Curavit is headquartered in Boston, US.